Effects of Intermittent Pneumatic Compression on Leg Blood Flow and Vascular Function After Spinal Cord Injury by Cialdella, Lena Marie
The University of Southern Mississippi 
The Aquila Digital Community 
Master's Theses 
Spring 5-2016 
Effects of Intermittent Pneumatic Compression on Leg Blood 
Flow and Vascular Function After Spinal Cord Injury 
Lena Marie Cialdella 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/masters_theses 
 Part of the Exercise Science Commons 
Recommended Citation 
Cialdella, Lena Marie, "Effects of Intermittent Pneumatic Compression on Leg Blood Flow and Vascular 
Function After Spinal Cord Injury" (2016). Master's Theses. 179. 
https://aquila.usm.edu/masters_theses/179 
This Masters Thesis is brought to you for free and open access by The Aquila Digital Community. It has been 
accepted for inclusion in Master's Theses by an authorized administrator of The Aquila Digital Community. For 
more information, please contact Joshua.Cromwell@usm.edu. 
  
 
 
 
 
 
 
EFFECTS OF INTERMITTENT PNEUMATIC COMPRESSION ON LEG BLOOD 
FLOW AND VASCULAR FUNCTION AFTER SPINAL CORD INJURY 
by 
Lena Marie Cialdella 
A Thesis 
Submitted to the Graduate School 
and the School of Kinesiology  
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
Approved: 
 
 
________________________________________________ 
Dr. Daniel Credeur, Committee Chair 
Assistant Professor, School of Kinesiology 
________________________________________________ 
Dr. Scott Piland, Committee Member 
Professor, School of Kinesiology 
________________________________________________ 
Dr. David Dolbow, Committee Member 
Assistant Professor, School of Kinesiology 
________________________________________________ 
Dr. Karen S. Coats 
Dean of the Graduate School 
 
 
 
May 2016 
ii 
 
ABSTRACT 
EFFECTS OF INTERMITTENT PNEUMATIC COMPRESSION ON LEG BLOOD 
FLOW AND VASCULAR FUNCTION AFTER SPINAL CORD INJURY 
by Lena Marie Cialdella 
May 2016 
Intermittent pneumatic compression (IPC) can increase leg blood flow (BF) in 
able-bodied persons. Whether IPC can alter leg BF and improve vascular function in 
people with SCI is currently unknown. PURPOSE: To test the hypothesis that acute IPC 
will increase leg BF, and improve vascular function in SCI. METHODS: Participants 
(n=8; injury level: T3 and below; A.S.I.A. class A-C; age: 41±17 yrs) were recruited for a 
1-hour IPC session performed in one leg (experimental leg; EXP), with the other serving 
as a control (CON). IPC consisted of sequential, foot-to-calf compressions (4-s inflate, 
16-s deflate; 3 compressions/min). Posterior-tibial artery BF (Doppler-ultrasound) was 
examined at rest, and at 15 and 45 mins of IPC. Vascular function was assessed using the 
flow-mediated dilation approach (FMD) before and after IPC. RESULTS: Resting 
posterior-tibial artery diameter, BF, FMD% and FMD normalized to shear area-under-
curve (FMD%/AUC) were similar between legs at rest. A two-way repeated measures 
ANOVA (leg x time) revealed that during IPC, BF tended to increase (P=0.063) in EXP 
leg (8±2 to 11±3 mL/min at 15 mins; +42±23%), with no change occurring in the CON 
leg (9±4 to10±5 mL/min at 15 mins). No main effects were noted for FMD following 
IPC; however, 7 of 8 subjects demonstrated increases in FMD%/AUC for EXP leg 
(+89±55% improvement; P=0.095, d= 0.362). CONCLUSION: Though no statistical 
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difference was found, there were notable effect sizes reported, thus giving the study 
further explanation of merit. 
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CHAPTER I  
INTRODUCTION 
More than a quarter of a million Americans are currently living with a spinal cord 
injury (SCI), with approximately 12,000 new cases occurring each year (National 
Institute of Neurological Disorders and Stroke [NINDS], 2015). These individuals also 
have a considerably higher pre-mature death rate (228%) compared to able-bodied (AB) 
individuals, which is largely attributable to cardiovascular and metabolic diseases (Groah 
et al., 2012; Myers, Lee, & Kiratli, 2007; Sabatier et al., 2006). Furthermore, the lifetime 
cost for an individual living with SCI in the U.S. is estimated to be >$3 million, with 
annual expenses for SCI treatment across the nation being >$9 billion each year (National 
Spinal Cord Injury Statistic Center [NSCISC], 2015). This presents a major, albeit 
potentially modifiable, public health challenge.  
Increased cardio-metabolic risk after SCI stems from unhealthy body composition 
changes (i.e., loss of muscle and bone mass and increased fat mass), along with 
impairments in vascular health, particularly in the legs (Hitzig, Miller, Eng, & 
Sakakibara, 2012; Myers et al., 2007; Phillips & Krassioukov, 2015; West, Alyahya, 
Laher, & Krasioukov, 2013). Importantly, vascular dysfunction precedes the 
development of numerous chronic disease states, including ischemic heart disease, type 2 
diabetes mellitus, and stroke (Grundy et al., 1999; Libby, Ridker, & Maseri, 2002; 
Thijssen et al., 2012). Therefore, strategies sought to improve vascular function in SCI 
are vital to improving the cardio-metabolic health profile and reducing premature 
mortality in this population.   
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In AB individuals, vascular function is maintained through regular elevations in 
blood flow induced shear stress which occur during walking and other forms of physical 
activity. Shear stress, which represents the frictional force of blood moving across the 
vascular endothelium, stimulates endothelial-derived vasodilators, most notably, nitric 
oxide, which promote smooth muscle relaxation and increased blood flow to the 
physically active region (Thijssen et al., 2009). Nitric oxide also performs a myriad of 
anti-atherogenic functions and is considered the most important molecule governing 
endothelial health (Green, Jones, Thijssen, Cable, & Atkinson, 2011).  
Due to paralysis of the lower extremities, individuals with SCI cannot voluntarily 
engage the lower-body. Wheelchair operation, as well as adapted physical activities (e.g., 
wheelchair basketball, quad rugby, and adapted tennis) provide the SCI individual an 
opportunity to engage the upper-body, which in turn provides some beneficial systemic 
effects on cardio-metabolic health outcomes, such as reducing traditional risk factors of 
cardiovascular disease (CVD), such as blood lipid levels, and indices of body 
composition (Myers et al., 2007; Phillips et al., 2015; Totosy de Zeptnek, Ditor, Au, & 
MacDonald, 2015). However, the vasculature of the lower extremities still remain 
vulnerable to pathology (Credeur, Stoner, & Dolbow, 2016). The legs of individuals with 
SCI can be exercised via functional electrical stimulation (FES). This technology works 
by sending electrical impulses via leads placed on the quadriceps, hamstring, buttocks, 
and calf muscles, in a sequence which allows an individual with paralysis to perform leg 
ergometry exercise (Kressler, Ghersin, & Nash, 2014). Importantly, FES cycling use has 
been shown to be effective in improving body composition and leg vascular function with 
regular use (Griffin et al., 2009; Stoner, Sabatier, Mahoney, Dudley, & McCully, 2007). 
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Unfortunately, FES cycles are expensive (~$20,000) and a physician’s prescription is 
required for use, making this technology not readily accessible to a majority of 
individuals with SCI. 
Recent evidence demonstrates that intermittent pneumatic cuff compression (IPC) 
applied to the calf and foot can also acutely increase blood flow and shear stress in leg 
arteries of able-bodied individuals (Sheldon et al., 2012). IPC is a non-invasive FDA 
approved therapy commonly used to treat individuals with symptoms of venous 
insufficiency and claudication pain in peripheral arterial disease (Chang et al., 2012; 
Roseguini et al., 2012; Sheldon, Roseguini, Laughlin, & Newcomer, 2013). This therapy 
is performed by inflating and deflating pneumatic cuffs, which are secured around the 
calf and foot region, in regular intervals for a period of time (i.e., 1 hour, 3 inflation 
cycles/minute) to simulate the mechanical compression of muscle contractions. While the 
use of IPC in clinical AB populations has been extensively tested (Delis, Azizi, Stevens, 
Wolfe, & Nicolaides, 2000a; Delis et al., 2000b; Labropoulos et al., 2005; Manfredini et 
al., 2014; Roseguini et al., 2012; van Bremmelen, Char, Giron, & Ricotta, 2003), the 
efficacy of its use for improving vascular health in individuals with SCI is currently 
unknown.  
Therefore, the purpose of this study was to determine whether a single IPC 
session can acutely enhance blood flow and vascular function in the lower limbs of those 
with SCI. We hypothesized that a single session of IPC will transiently increase blood 
flow and shear rate, thus, providing an acute enhancement in vascular endothelial 
function of lower extremity arteries in people with SCI. 
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CHAPTER II 
METHODS 
Experimental Design 
 This study consisted of a pre-test with multiple post-tests intervention control 
group experimental design. 
Subjects 
Eight subjects with chronic SCI participated in this study. Subjects were recruited 
from the surrounding Hattiesburg and Gulfport, MS area. Following a detailed 
explanation of the experimental measures and protocols, each subject provided written 
informed consent prior to participating in any facet of the study. Inclusion for 
participation consisted of the following:  ≥2 years post spinal injury; T3 neurological 
injury level and below; American Spinal Injury Association (ASIA) classification A, B 
and C; wheelchair reliant; 18-75 years of age. Exclusion criteria consisted of pressure 
wounds on the buttocks or feet, unhealed bone fractures or history of fragility fractures, 
severe osteoporosis (T-score of -4 or less), uncontrolled autonomic dysreflexia, unstable 
cardiovascular or metabolic disease, and <2 years post spinal injury. All experimental 
procedures and protocols conformed to the Declaration of Helsinki and were approved by 
the University of Southern Mississippi Institutional Review Board (Appendix A). 
Experimental Measurements 
Cardiovascular Measures. Subjects were instrumented with a lead II surface 
electrocardiography (ECG) (Logiq P5; GE Medical systems, Milwaukee, WI, USA) for 
continuous measurement of heart rate (HR), and blood pressure (BP) was measured via 
automated sphygmomanometry (Omron HEM907XL- Intellisense) performed on the 
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right upper-arm periodically during the experimental protocol. Posterior-tibial artery 
diameter and blood velocity signals were obtained using a high resolution (30 Hz) 
duplex-Doppler ultrasound system (Logiq P5; GE Medical systems, Milwaukee, WI, 
USA). The artery was imaged 3-5 cm superior to the calcaneus and ~1 cm posterior to the 
medial malleolus on the right and left ankles, separately, using an 11-MHz linear array 
transducer. Diameter and blood velocity signals were obtained simultaneously in duplex 
mode, operating at a pulsed Doppler frequency of 5-MHz. Measurements were performed 
with the velocity cursor placed mid-vessel and the sample volume was adjusted to 
encompass the entire vessel lumen without extending beyond it. To ensure consistency 
and stability in the measurement, probe placement was marked on the skin using a 
permanent marker, and the transducer was stabilized using a custom-designed clamp. In 
addition, all probe settings were kept consistent for each limb throughout the study. 
Body Composition Measures. Height was determined with a standard tape 
measure with the subject in a supine position. Every effort was made to extend the knee 
fully for precise measurement. Weight was determined through the use of a wheelchair 
scale (Scale Tronix). Subjects were weighed while in their wheelchair, after which they 
were transferred to the examination table using a mechanical lift (Invacare), then the 
wheelchair weighed separately. Dual-Energy X-Ray Absorptiometry (DEXA) (Lunar 
Prodigy Advance) was performed to determine total body and regional lean and fat mass, 
%-body fat (%BF), and total body bone mineral density (BMD). Importantly, T-scores 
for BMD were used to determine possible osteopenia and osteoporotic values. To do this, 
subjects were transferred from their wheelchair, via the mechanical lift, and positioned 
supine on the DEXA scanner. Their legs were strapped proximal and distal to the knees 
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to steady the distal femur and proximal tibia, with a slight internal rotation of the hips to 
position the greater trochanter in the best scanning position, and for the safety of the 
participant in the event of an untimely muscle spasm (Charmetant, Phaner, Condemine, 
& Calmels, 2010; Shields, Schlechte, Dudley-Javoroski, Zwart, & Clark et al., 2005). 
Experimental Protocol 
Study Visits 
Screening Study Visit. On the first day, subjects provided written informed 
consent (Appendix B), and completed a detailed medical history questionnaire (Appendix 
C), and  a leisure time physical activity questionnaire for people with spinal cord injury 
(LTPAQ-SCI)© (Ginis, Phang, Latimer, & Arbour-Nicitopoulos, 2010) (Appendix D). A 
familiarization session was then performed to acquaint subjects to the experimental 
measurements (i.e., Doppler-Ultrasound, and mechanical lift), and to ensure quality 
ultrasound images could be obtained. The leg that provided the best quality image served 
as the experimental leg (EXP) and the other leg served as the control (CON). Following 
the vascular screening, anthropometric measures and the DEXA scan were performed. 
For convenience, some subjects completed all facets of the study in a single visit.    
Experimental Study Visit. Study visit two consisted of the experimental visit 
(Figure 1). All subjects reported to the laboratory during the morning hours (6:00 – 11:00 
am) following an overnight fast. Subjects also refrained from caffeine and alcohol for 12 
hours, and any strenuous physical activity for 24 hours. After providing a review of the 
experimental procedures, the subjects were then transferred to the examination table 
using the mechanical lift, positioned semi-recumbent, and instrumented for ECG, BP, and 
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Doppler-Ultrasound measurements. Subjects rested quietly for 30 minutes before baseline 
testing was performed. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Timeline for the experimental study visit.  
Vascular Function Testing. All testing was performed in a dimly lit, temperature 
(22-23° Celsius) and humidity (~50%) controlled room. Following 30 minutes of semi-
recumbent rest, vascular function was assessed in both posterior-tibial arteries by the 
same ultrasonographer. The rationale for choosing this artery stems from previous 
evidence suggesting that the posterior-tibial artery experiences a lesser degree of atrophy 
following traumatic SCI, as compared to larger vessel of the leg (e.g., popliteal and 
femoral arteries) (Stoner et al., 2007). Furthermore, examining the posterior-tibial artery 
was a unique aspect, given that it permitted the assessment of vascular changes within the 
region of compression, in contrast to a more proximal vessel (i.e., popliteal).  
30 min rest Subject  
arrival; 
Instrumentation  
• FMD tests 
repeated on 
both legs 
• EXP leg 
examined first 
• Data backed-up 
and analyzed 
off-line 
• Duplex 
Doppler-US 
• Baseline 
Measures 
• ECG, BP, BF, 
and FMD test 
on both legs 
• IPC intervention 
(60 min) in 1 
leg, other leg 
control (CON) 
• BF measured at 
15- and 45-mins 
during IPC 
• ECG and BP 
monitored 
periodically 
 
1. 2. 3. 
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Vascular endothelial function testing was performed using the Flow-Mediated 
Dilation (FMD) technique, in accordance with previously published guidelines (Corretti 
et al., 2007; Thijssen et al., 2010). After the attainment of a quality ultrasound signal, two 
minutes of baseline data were recorded, followed by inflation of a proximally placed 
pneumatic cuff (220 mmHg) (Hokanson; Bellevue, WA), positioned ~1 cm distal from 
the fibular head around the subject's calf, for 5 minutes. Data were recorded continuously 
from the last 30 seconds of occlusion and until 4 minutes post cuff-release using an 
image capturing system (El Gato), and analyzed off-line via an automated edge-detecting 
software (QUIPU, FMD Studio) by the same study personnel, separate from the 
ultrasonographer. The 3 largest diameter values following cuff-release were averaged and 
considered the peak change, and used to calculate FMD as described under Data Analysis 
below. Baseline posterior-tibial artery FMD measurements were randomized between 
limbs, and were separated by at least 10 minutes. Absolute blood flow (BF in mL/min) 
data were also recorded and analyzed off-line on the Doppler Ultrasound unit (GE, Logiq 
P5). It is important to note, that while between-day reliability was not performed on SCI 
individuals for this study, previous work has reported good day-day reliability of 
posterior-tibial artery FMD in AB individuals (Black, Cable, Thijssen, & Green, 2008). 
Furthermore, the stability of this measurement was examined after 60 minutes of quiet 
rest in SCI individuals (n=2), and importantly, no apparent differences were noted for 
posterior-tibial artery FMD% (e.g., baseline = 29±11%, vs. 60 mins rest=33±9%). 
Intermittent Pneumatic Compression. To best administer IPC, the same rapid 
inflation system used during vascular endothelial function testing, was also used to 
administer the intervention. To do this, two separate cuffs, one small cuff (SC5; 5 cm 
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bladder) positioned around the mid-foot and another larger cuff (CC17; 17 cm bladder) 
positioned around the calf (~1 cm distal to the fibular head) of the EXP leg, were 
connected to a single inflation unit (Hokanson E20-Rapid Cuff Inflator). During inflation, 
the foot cuff always inflated first (~0.5 second delay), followed shortly by the calf cuff, 
thus, providing a sequential foot-to-calf compression cycle, similar to that of a 
commercially available IPC device (e.g., ArtAssist®). In addition, the Hokanson cycle 
timer was adjusted to deliver three automated compressions per minute (4-s inflation/ 16-
s deflation) at 120 mmHg, over the course of an hour. Traditional IPC therapy (e.g. 
ArtAssist®) consists of 3-s inflation/ 15-sec deflation (Sheldon et al., 2012). The 
rationale for the timing adjustment in the current study was to account for an approximate 
1-s delay in the Hokanson inflation unit reaching the desired pressure. For proof of 
concept, we examined popliteal artery BF responses to 5 minutes of IPC therapy between 
this experimental (Hokanson) vs. traditional (ArtAssist®) IPC approach in one AB 
participant, and importantly, no marked differences were noted for the magnitude of 
initial increase (% mL/min) between devices (e.g., Hokanson=+166% vs. ArtAssist= 
+161%).  
Hemodynamics during IPC. To examine the hemodynamic profile, posterior-tibial 
artery blood velocity signals (antegrade and retrograde velocity) were acquired on both 
the Doppler-ultrasound and image capture software, as described in detail above. Three 
compression cycles (~1 minute of data), were recorded at baseline, and following minutes 
15 and 45 of IPC. Following 60 minutes of IPC therapy, the FMD tests were repeated in 
both legs. In order to detect the transient changes in vascular endothelial function, the 
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order of FMD tests was not randomized, and the EXP leg was always assessed 
immediately following completion of IPC (~3 mins post treatment).  
Analysis 
Data Analysis 
All ultrasound data were outsourced at 30-Hz, and acquired onto a designated 
laptop (Mac Book) using a commercially available analog video capture unit (El Gato). 
Data were then analyzed off-line, in accordance with guidelines (Thijssen et al., 2010), 
by playing pre-recorded videos through the Cardiovascular Suite software. A region of 
interest (ROI) was selected on each video to ensure a clear portion for the edge-detection 
software to analyze posterior-tibial artery diameters. Blood velocity signals were also 
simultaneously analyzed using the same software by obtaining the flow-envelope (area 
under tracing) for both the antegrade (positive area) and retrograde (negative area) 
velocity signals. Mean velocity was defined as the difference between antegrade and 
retrograde velocity signals. Blood flow (mL/min) was calculated as; 
(π*diameter/2)2*mean velocity*60. Blood flow was also analyzed on the Duplex 
Doppler-ultrasound using internal software (GE) in addition to analyses performed on the 
Cardiovascular Suite software.  
To determine BF and shear rate responses during IPC, velocity signals were 
analyzed and averaged between compression cycles in order to minimize any potential 
artifact from movement due to cuff inflation/deflation. Vascular endothelial function was 
determined as the peak change in posterior-tibial artery diameter from baseline following 
cuff release, and expressed in both absolute (mm) and relative (%) terms; i.e., FMD 
change=(peak diameter-baseline diameter)/baseline diameter*100.  Shear rate (s-1) was 
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calculated as 8*mean velocity/diameter (van Brussel, F, van Brussel, B, Hoeks, Roodt, & 
Henry et al., 2015) and shear rate incremental area-under-the-curve (AUC) up until the 
time (sec) peak diameter was calculated using the trapezoidal method (i.e., change in 
shear rate/second), and importantly, was used to normalize FMD% to the stimulus 
(FMD%/AUC) (Padilla et al., 2008; Thijssen et al., 2012). 
Statistical Analysis 
To examine differences between vascular function, and blood flow (BF) indices at 
rest, during, and after IPC therapy, separate 2-way (leg x time) repeated measures 
ANOVA’s were performed. Bonferroni post hoc tests were selected to examine possible 
interactions between study measurements. Independent sample T-tests were utilized to 
compare relative changes in BF and vascular function between legs (EXP vs. CON), pre 
and post IPC therapy. Cohen’s d effect sizes were also calculated to examine 
meaningfulness of changes in vascular function and BF between legs, pre to post IPC 
therapy. All statistical analyses were performed using Sigma Plot Analysis software and 
SPSS (IBM, Watson Analytics). Statistical significance was set a priori at p<0.05, and 
moderate to large effect sizes were considered clinically meaningful. 
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CHAPTER III 
RESULTS 
Subject Data 
Individual participant demographics are summarized in Table 1. The average age 
and duration of SCI was 41±6 years and 20±19 years, respectively. Within the cohort, 
three subjects had diagnosed metabolic disease (type 2 diabetes), and one had a history of 
cardiovascular complications (coronary artery disease). Importantly, all subjects were 
asymptomatic at rest and no differences were noted between the participant’s responses 
pre and post IPC, as compared to the cohort. 
Table 1 
Subject Demographics 
Subject Age 
(yrs) 
Sex Race Ht. (m) Wt. (kg) %BF BMD T-score Injury 
Level 
SCI 
(yrs) 
ASIA 
class 
1 
2 
3 
4 
5 
6 
7 
8 
 
Avg±Sd 
27 
53 
36 
75 
34 
33 
30 
35 
 
41±16 
M 
M 
M 
M 
F 
M 
F 
M 
C 
C 
C 
C 
AA 
AA 
C 
AA 
1.9 
1.8 
1.5 
1.8 
1.6 
1.8 
1.5 
1.7 
 
1.7±0.1 
103.8 
85.3 
50.5 
79.5 
109.5 
131.6 
60.2 
126.5 
 
93±26 
34 
40 
19 
35 
60 
42 
32 
45 
 
38±11 
1.42 
1.34 
1.08 
1.12 
1.12 
1.45 
1.07 
1.51 
 
1.3±0.2 
2.5 
1.4 
-1.7 
-1.2 
-0.1 
2.9 
-0.7 
3.7 
 
 
T-5 
T-12 
T-6 
T-3,4 
T-10 
T-9 
T-11 
T-12, 
L-1 
9 
34 
21 
60 
13 
10 
10 
2 
 
20±19 
A 
B 
A 
B 
B 
A 
C 
A 
 
Note. C (Caucasian), AA (African American), %BF (body fat percentage), BMD (bone mineral density), ASIA class (American 
Spinal Injury Association) classification scale. 
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Hemodynamic Responses to IPC 
Table 2 summarizes hemodynamic data at rest, and during IPC for both legs. 
Figure 2 represents a Doppler-Ultrasound image from one subject showing BF at baseline 
and following 15 mins of IPC in the EXP leg. Although not statistically significant, a 
majority of subjects demonstrated a biphasic pattern for BF and shear rate responses to 
IPC in the EXP leg (n=6), characterized by a transient increase (~50%) at 15 mins, with a 
return to baseline at 45 mins. When comparing peak Δ% in BF during IPC, occurring at 
either 15 or 45 mins, the EXP leg tended to show a positive response (+42±23%, 
P=0.063, d=0.27), with no change observed in the CON leg (-7±15%) (Figure 3). To 
note, CON leg BF data were not collected in one subject due to physical limitations (i.e., 
history of blood clots in that leg).  
Table 2 
Hemodynamic Variables at rest and during IPC 
 EXP Leg  CON Leg 
 Rest 15mins 45mins  Rest 15mins 45mins 
HR (bpm) 70±10 67±11 66±4  70±10# 67±11# 66±4# 
MAP (mmHg) 90±5 91±9 90±11  90±5# 91±9# 90±11# 
Diameter (cm) 0.17±0.01 0.17±0.05 0.17±0.007  0.15±0.2 0.16±0.1 0.16±0.2 
Mean Velocity(cm/sec) 6.3±1.2 6.6±2.0 5.0±1.1  7.7±2.7 7.1±3.2 6.6±2.8 
BF (ml/min) 8.0±2.4 10.7±3.2 6.6±1.5  9.0±3.5 10.2±5.2 10.0±5.1 
Ant Shear (s-1) 254 ±111 258±141 215±85  304±209 298±265 272±200 
Ret Shear (s-1) -39±37 -37±35 -39±34  -28±27 -28±37 -28±37 
Mean Shear (s-1) 215±125 221±150 178±89  274±226 270±280 245±214 
Note: HR (Heart Rate), MAP (Mean Arterial Pressure), BF (Blood Flow), Ant (Antegrade), Ret (Retrograde). 
#
same data as EXP leg. 
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Figure 2. Blood Flow Response after 15 minutes of IPC. Image is a representation of 
blood flow responses to IPC as seen on the Duplex Doppler-ultrasound. Panels A) and B) 
depict the blood flow pattern of the same participant at baseline, and after 15 minutes of 
IPC in the EXP leg, respectively. Note the approximate 50% increase in mean velocity as 
shown by the bottom sweep in each panel 
 
 
 
 
 
 
 
 
Figure 3.  Blood Flow Response during IPC. Panel A) depicts blood flow measures 
during IPC in the EXP leg and CON leg. Panel B) depicts the percent change (%Δ) of 
peak blood flow between the EXP and CON leg, respectively. 
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Vascular Endothelial Function Responses to IPC 
Table 3 summarizes results from FMD testing before and after IPC therapy for 
both the EXP (n=8) and CON (n=6) leg. Of note, FMD testing was not performed on the 
CON leg in two subjects due to physical limitations (n=1), and an inability to obtain 
optimal image quality for analysis (n=1). 
Table 3 
Vascular Endothelial Function before and after IPC 
       EXP pre      EXP post CON pre CON post 
Base Diam. (cm) 1.7 ± 0.1 1.7 ± 0.1 1.5 ± 0.1  1.6 ± 0.1 
Peak Diam. (cm) 2.2 ± 0.1 2.3 ± 0.1 2.0 ± 0.2  2.0 ± 0.2 
Abs. Δ (mm) 0.4 ± 0.1 0.5 ± 0.1 0.5 ± 0.1  0.3 ± 0.1 
%Δ      24.7 ± 4.0     32.8 ± 7.8      30.6 ± 3.6    21.9 ± 5.3 
Peak Shear (s-1)      648 ± 57      603 ± 69 493 ± 120  469 ± 113 
Shear AUC  18481 ± 3448  15398 ± 2201   15971 ± 6001 14221 ± 3945 
Note: Diam. (Diameter), Abs. (Absolute), AUC (Area under Curve) 
Figure 4 represents individual data responses for normalized FMD pre and post 
IPC for both legs. For FMD%/AUC, no statistical differences were noted for changes 
between the EXP and CON leg, pre- and post-IPC. However, when these data were 
expressed as a change score (%Δ) (Figure 5), the EXP leg tended to show an 
improvement in a majority of subjects (+89±55%, P=0.095; effect size d= 0.362), with no 
change occurring in the CON leg (-21±21%).  
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Figure 4. Normalized FMD Response for Individual Data pre- and post-IPC. This graph 
depicts individual and mean summary data for FMD%/AUC at baseline and 60-minutes 
post-IPC for the EXP and CON leg.  
 
 
 
 
 
 
 
 
Figure 5. Improvement in Vascular function following IPC. Graph represents the percent 
improvement (%Δ) in FMD%/AUC between EXP and CON legs following 60 mins IPC. 
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CHAPTER IV 
DISCUSSION 
This study sought to determine the efficacy of a novel therapy, IPC, in targeting 
leg blood flow and vascular function in people with SCI. Uniquely, we show for the first 
time, that IPC can be implemented safely in paralyzed legs of people with paraplegic 
SCI. Contrary to our initial hypotheses, there were no significant main effects of IPC to 
increase blood flow, or to improve vascular function. However, there was a tendency for 
a majority of subjects to show positive effects on these study outcomes. Collectively, 
these preliminary data demonstrate that one hour of IPC therapy may acutely increase leg 
blood flow, and improve vascular function in some people with SCI.   
Leg Blood Flow 
Effects of IPC on Leg Blood Flow 
Previous research has demonstrated that IPC can transiently increase arterial BF 
and shear rate when applied to the lower legs of AB individuals. For example, one study 
reported that popliteal artery BF and shear rate increased two-fold within the first 15 mins 
of IPC (Sheldon et al., 2012). In other studies, IPC significantly increased popliteal artery 
inflow in patients with peripheral vascular disease (Delis et al., 2000a), as well as altered 
popiteal venous outflow in tetraplegic SCI subjects (Nash, Mintz, Montalvo, & Jacobs, 
2000). Uniquely, for the first time, we examine posterior-tibial artery BF responses to 
IPC in paraplegic SCI subjects. In this study, no significant main effects were noted for 
IPC to alter leg BF and shear rate in people with SCI. One potential explanation for the 
lack of agreement between our data and others could be attributed to the artery chosen to 
undergo Doppler-ultrasound scanning, which was the posterior-tibial artery near the 
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ankle. Because of its location (i.e., between compression cuffs), it is possible that the 
hyperemic stimulus to IPC may have been dampened, thus, reducing our ability to 
examine a measurable effect on conduit artery blood flow. Interestingly, our data did 
show a tendency (P=0.063; d=0.265) for peak increases in blood flow to be greater in the 
EXP, as compared to the CON leg. After further examination of these data, we found that 
some individuals achieved a peak response within 15 mins (N=6), while others took as 
long as 45 mins (N=2) to achieve this peak BF response. Therefore, it is plausible that 
some individuals may have reached their peak increase in BF beyond the measurement 
intervals (i.e., between 15 and 45 mins). Future work will be needed to further examine 
the time course of BF responses to IPC in people with SCI. 
While this study was not designed to test mechanisms, a discussion of the 
potential contributors to hyperemia following mechanical compression is worth 
considering. IPC therapy has been shown to provide a muscle pump-like effect on the 
peripheral vasculature (Delis, Nicolaides, Labropoulos, & Stansby, 2000c). Following 
application of an external pressure (120 mmHg), the resulting vascular compression 
would, in theory, displace venous volume back to the heart, widen the arterial-venous 
pressure gradient, and in turn, increase arterial inflow within the stimulated region 
(Laughlin, 2005). Repeated compressions could also further elevate arterial inflow 
through increased shear stress on the arterial wall, with subsequent production and 
release of endothelial-derived vasodilators. For example, IPC performed bilaterally on the 
legs in rats has been shown to increase the expression of endothelial derived nitric oxide 
synthase—the enzyme catalyzing the reaction to produce nitric oxide—as well as, 
stimulate nitric oxide-mediated vasodilation, with subsequent hyperemia within the 
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microvasculature of cremaster muscles (Chen et al., 2002; Liu, Chen, Seber, Johnson, & 
Urbaniak, 1999). Whether this mechanism plays a role for the hyperemic response to IPC 
in humans, warrants further investigation.  
Leg Vascular Function 
Effects of IPC on Leg Vascular Function 
Repetitive increase in shear stress (i.e., dynamic exercise and external peristaltic 
pneumatic compression—EPC) have been shown to transiently modulate vascular 
endothelial function in healthy AB individuals (Martin, Borges, & Beck, 2015; Padilla, 
Harris, & Wallace, 2007). Given this evidence, we posited that IPC could also serve as a 
means to enhance leg vascular function in people with SCI. Contrary to this hypothesis, 
no significant main effect was noted for IPC to alter vascular function in SCI. This 
finding is in agreement with one report demonstrating that acute IPC does not improve 
leg vascular function in healthy AB individuals. Our data did show a tendency for FMD 
normalized to shear AUC to improve in the EXP leg (P=0.095; d=0.362), with a majority 
of individuals exhibiting positive effects (7 out of 8). This leaves the question of whether 
IPC may influence vascular function in some individuals with SCI, and not others. 
Interestingly, a more recent report indicated that 60 minutes of EPC applied to the legs 
can indeed significantly improve leg vascular function (i.e., popliteal artery) in healthy 
AB individuals (Martin et al., 2015). It is important to emphasize that this study utilized a 
different type of compression stimulus consisting of a sequential distal-to-proximal 
pneumatic compression applied to 5 regions on the leg at a lower pressure (i.e., 70 mmHg 
compared to 120 mmHg), but different tempo (60-s inflate/30-s deflate, for 1 hour). This 
variation of the compression stimulus likely produced their observed improvement in 
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vascular function, as opposed to the previous IPC research in AB individuals (Sheldon et 
al., 2012). Indeed, future studies are warranted to determine whether alterations in the 
IPC stimulus (i.e., number of compression regions, inflation pressure, and duty cycle) can 
alter vascular function in people with SCI, as well as AB individuals.   
Limitations and Clinical Implications 
Experimental Limitations 
There are a few experimental limitations that are worth discussing. Our subjects 
varied in age (27-75 years), neurological injury level, duration of SCI, and ASIA 
impairment, all of which could have confounding influences on study results. Given the 
inherent difficulty in matching people with SCI, we had to temper our inclusion criteria 
to accept of wide range of individuals to achieve a sufficient sample number. Indeed, 
future efforts will be needed to discern whether such factors could play a role in 
modulating vascular responses to IPC therapy. Still, with a low sample number, and 
heterogeneous SCI group, our data showed tendency and moderate effects for IPC to 
increase BF, and improve vascular function in some individuals, which perhaps, warrants 
further investigation with a larger, and more homogenous SCI cohort. 
Uniquely, our study investigated the posterior-tibial artery which permitted the 
examination of vascular changes within the region of compression. However, given this 
location, it is possible that the hyperemic stimulus may have been minimized, thus, 
reducing our ability to examine a measureable effect. Future research will be needed to 
determine whether a more proximal vessel, such as the popliteal artery or femoral artery, 
responds differently to acute, and or chronic IPC in people with SCI. 
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Clinical Implications 
A majority of people with SCI are subjected to prolonged periods on inactivity 
due to paralysis below the level of injury. It is well known that physical activity has 
positive effects of cardio-metabolic health outcomes (American College of Sports 
Medicine, 2014). Interestingly, a recent report indicated that achieving the physical 
activity recommendations in SCI through 16 weeks of upper-body exercise does not 
provide comparable benefits as AB individuals, in terms of improving cardio-metabolic 
health outcomes (Totosy de Zepetnek et al., 2015). Upper-body exercise training alone 
may not provide a sufficient stimulus to vulnerable regions, like the paralyzed legs 
(Credeur et al., 2016). Therefore, targeting this region with alternative efficacious, and 
economically viable therapies may provide a means to further combat cardio-metabolic 
health declines, when used alone, or possibly in combination with other traditional 
approaches (e.g., FES cycling, and arm ergometry). The exploratory nature of this project 
provides evidence to support that external stimuli applied to the paralyzed region may 
have beneficial effects in some individuals within our study sample. Therefore, future 
research should continue examining whether novel therapies, like IPC, can serve as an 
effective means to enhance vascular health outcomes in people living with SCI. 
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CHAPTER V 
CONCLUSION 
In summary, these preliminary data indicate that one hour of IPC therapy can be 
implemented safely in the paralyzed legs of people with SCI. While no statistical 
differences were noted for study outcomes, a majority of subjects tended to exhibit 
positive effects on blood flow (P=0.063; d=0.265) and vascular function (P=0.095; 
d=0.362). Therefore, future studies should further evaluate the effects of IPC therapy on 
cardio-metabolic health outcomes when performed acutely and chronically in people 
living with SCI. 
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APPENDIX A 
IRB APPROVAL
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APPENDIX B 
INFORMED CONSENT 
 
  
25 
 
 
  
26 
 
 
27 
 
   
28 
 
APPENDIX C 
HEALTH HISTORY FORM 
University of Southern Mississippi, Laboratory of Applied 
Physiology 
Medical Health History Form  
All of the information provided in this form is voluntary. 
Date: Biographical information: 
Last Name:                                                                  First:                                                   MI: 
Occupation:                                                                 Email: 
Home Phone: (        )                      Work: (       )                       Cell: (        ) 
Address: 
DOB:       /           /            Age:           Gender  M / F     Height:            Weight: 
Highest Education Achieved: 
Race: What race do you consider yourself to be? Select one or more of the following: 
 
Hispanic or Latino - A person of Mexican, Puerto Rican, South or 
Central American, or other Spanish culture or origin, regardless of race. 
The term "Spanish origin," can be used in addition to "Hispanic or 
Latino." 
 
American Indian or Alaska Native - A person having origins in any 
of the original peoples of North, South, of Central America, and who 
maintain a tribal affiliation or community attachment. 
 
Asian- A person having origins in any of the originals peoples of the Far 
East, Southeast Asia, or the Indian subcontinent, including, for example, 
Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the 
Philippine Islands, Thailand, and Vietnam. (Note: Individuals from the 
Philippine Islands have been recorded as Pacific Islanders in the 
previous data collection strategies.) 
 
Black or African American - A person having either origins in any of 
the black racial groups of Africa. "Haitian" can be used in addition to 
"Black" or "African American." 
 
Native Hawaiian or Pacific Islander - A person having origins in 
any of the original peoples of Hawaii, Guam, Samoa, or other Pacific 
Islands. 
 
White - A person having origins in any of the original peoples of 
Europe, the Middle East, or North Africa. 
Primary Care Physician: 
Name:                                                                                        Office Phone: 
Address: 
Emergency Contact: 
Name: Relationship:                                                 Phone # 
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Medications: Include over the counter drugs/ oral contraceptive/ dietary supplements 
Name/ Dosage/ How often taken: 
  
  
  
  
Allergies: 
  
Smoking History: 
Do you smoke Cigarettes?   Pipe/ Cigar?  Other?   If you quit, what year did you quit? 
# of packs smoked per day ________________      For how many years _________________ 
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Medical Health History Form       Page 2 
Alcohol Consumption History: 
Do you currently drink alcohol?                    If you drank alcohol previously, when did you stop? 
If you ever did drink alcohol, what is (was) the volume consumed?                                                                                                    
_____________# ounces / day       for _______________ # of years 
Medical History: 
NO YES  Please explain any "YES" answers 
    high blood pressure 
    chest pain/ history of heart attack 
    extra heart beats or racing 
    abnormal electrocardiogram (ECG) 
    other heart trouble (e.g. murmur, valve problems) 
    high cholesterol 
    diabetes 
    seizures 
    stroke 
    fainting spells 
    anxiety (diagnosed) 
    depression (diagnosed) 
    recurrent fatigue 
    insomnia 
    thyroid problems 
    difficulty breathing 
    emphysema/ asthma/ chronic bronchitis 
    tuberculosis 
    chronic infection 
    stomach/ GI problems 
    hepatitis 
    bleeding disorder 
    kidney/ urinary problems 
    joint injuries/ joint pain 
    arthritis (rheumatoid or osteoarthritis) 
    migraine headaches 
    vision problems (exclude corrected near/ far sightedness) 
    surgical procedures 
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Medical Health History Form         Page 3 
 
Inclusion Criteria for SCI Participants: 
1. Adults with chronic T3 – L5, (AISA- A, B, or C) SCI (2 years post injury) 
2. Wheelchair reliant (unable to walk with or without support) 
3. Between 18 and 75 years of age 
Exclusion Criteria: 
1. No evidence of pressure wounds on buttocks or feet 
2. Unhealed bone fracture or history of low trauma (fragility) fracture 
3. Severe Osteoporosis (T score of -4 or less or a history of fragility fractures) 
4. Uncontrolled autonomic dysreflexia 
5. Less than 2 years post injury 
 
Where is the location of your injury? 
How long have you had the diagnosis of SCI? 
Injury Questions: 
NO YES Please explain any “YES” answers 
  Do you have a history of uncontrolled autonomic dysreflexia? 
  Have you suffered a bone fracture recently? 
  Have you been diagnosed with orthostatic hypotension? 
  Have you been diagnosed with Osteoporosis? 
  Do you have a history of bone fragility fractures? 
  Do you have any decubitus ulcers or ulcers on the feet? 
 
 
Please sign and date: 
Signature: __________________________________________________________  Date: 
_______________________ 
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APPENDIX D 
LTPAQ-SCI
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